SQI Diagnostics Inc.
SQIDF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.19 | 0.05 | -0.02 | -0.04 |
| FCF Yield | -2.65% | -4.88% | -5.98% | -2.48% |
| EV / EBITDA | -26.97 | -21.40 | -12.60 | -25.78 |
| Quality | ||||
| ROIC | -508.96% | -59.15% | -93.92% | -28.27% |
| Gross Margin | 51.57% | 27.07% | -27.79% | 35.73% |
| Cash Conversion Ratio | 0.21 | 0.52 | 0.29 | 0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 43.74% | 104.81% | 99.33% | 70.86% |
| Free Cash Flow Growth | 59.05% | 25.77% | -63.28% | 84.02% |
| Safety | ||||
| Net Debt / EBITDA | -9.26 | -6.33 | -3.37 | -4.43 |
| Interest Coverage | -5.09 | -2.36 | -3.36 | -10.00 |
| Efficiency | ||||
| Inventory Turnover | 1.84 | 0.28 | 1.24 | 0.49 |
| Cash Conversion Cycle | -2,179.35 | -876.21 | -79.55 | -95.79 |